OpenAI Foundation commits $125M+ in science grants, funding open FDA failure archive
owl_posting · x · 2026-09-16
The OpenAI Foundation announced over $125M in grants and its second science program. A key grant funds CTD Commons, built on Ruxandra Teslo's Launch Sequence proposal: buying FDA filings and clinical trial results from failed biotechs to create an open-source library. FDA submissions contain unmatched detail on trial design, manufacturing and safety reviews but stay private, structurally favoring pharma incumbents; unlocking this data could let AI auto-draft submissions, predict approval outcomes and speed FDA timelines.
More from Companies & People
- Grok, Cursor and X account merge creates absurd login loop for users — oran_ge · 2026-11-02
- Gradio teases NeurIPS 2026 ML Intern paper-reproduction hackathon — Gradio · 2026-11-02
- iOS developers say App Store review times have stretched from two weeks to a month — tinyfool · 2026-11-02
- Stratechery: Google's earnings miss mirrors Facebook's—but its agent play is bolder than credited — Stratechery · 2026-11-02
- Doctors wait up to a year to start: PE-backed staffing firm's Excel-bound credentialing process laid bare — alex_verem · 2026-11-02
- Claude upgrade-page traffic rebounded to 17.6M in September, near May's 18.6M peak — firstadopter · 2026-11-02